Table of Contents
Chemotherapy Research and Practice
Volume 2012, Article ID 901320, 10 pages
http://dx.doi.org/10.1155/2012/901320
Review Article

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab

1Aerodigestive and Thoracic Tumor Program, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA
2Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA
3UCSF School of Medicine, University of California San Francisco, San Francisco, CA 94115, USA

Received 14 May 2012; Accepted 22 July 2012

Academic Editor: Basil El-Rayes

Copyright © 2012 Scott A. Kono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Scott A. Kono, Missak Haigentz Jr., Sue S. Yom, and Nabil Saba, “EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab,” Chemotherapy Research and Practice, vol. 2012, Article ID 901320, 10 pages, 2012. https://doi.org/10.1155/2012/901320.